INVESTOR ALERT: Investigation of Soleno Therapeutics, Inc. (SLNO) Announced by Holzer & Holzer, LLC

ATLANTA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Soleno Therapeutics, Inc. (“Soleno Therapeutics” or the “Company”) (NASDAQ: SLNO) complied with federal securities laws. On August 15, 2025, Scorpion Capital released a report alleging, among other things, that Soleno Therapeutics’ phase 3 clinical trials and withdrawal studies conducted in furtherance of the Company’s efforts to obtain approval of its drug, VYKAT™ XR, “lack credibility and were plagued with numerous pr ...